ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

IBIO vs CLNN // ALTMAN Z-SCORE & DEBT/EQUITY

iBio Inc. (NASDAQ) VS. Clene Inc. (NASDAQ) • 15-METRIC TALLY: IBIO 3 — CLNN 1
■ METRIC PARITY
balance-sheet
0.20
balance-sheet
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IBIO VS. CLNN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC IBIO CLNN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 78.50% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 77.80% -41.50% +119.30 IBIO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 IBIO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 40.8 42.8 -2.00 CLNN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $51.4M $51.3M $126.9K IBIO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR IBIO REV CLNN REV IBIO GROSS % CLNN GROSS % IBIO FCF CLNN FCF
FY 2025 $400.0K $200.0K — 78.5% -$15.3M -$18.6M
FY 2024 $225.0K $342.0K — 79.5% -$18.8M -$21.3M
FY 2023 $82.2M $654.0K — — -$30.4M -$30.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IBIO // BETA —
CLNN // BETA —